SWK Holdings Corp — fact timeline

SWK Holdings Corp terminated Credit Agreement with First Horizon Bank (effective 2026-04-06).

“on April 6, 2026, the Company and its subsidiaries terminated all outstanding lender commitments, under that certain Credit Agreement, dated June 28, 2023, by and among the Company, SWK Funding LLC, a Delaware limited liability company and First Horizon Bank (as amended, modified or otherwise supplemented from time to time, the “Credit Agreement”).”

SWK Holdings Corp amended Second Supplemental Indenture with Wilmington Trust, National Association valued at $30.0 million aggregate principal amount (effective 2026-04-06).

“on April 6, 2026, the Company entered into the Second Supplemental Indenture (the “Second Supplemental Indenture”), between the Company and Wilmington Trust, National Association, as trustee (the “Trustee”), to the Indenture, dated as of October 3, 2023, between the Company and the Trustee (as amended and supplemented by the First Supplemental Indenture, dated as of October 3, 2023, the “Base Indenture”), under which the Company issued $30.0 million aggregate principal amount of its 9.00% Senior Notes due 2027 (the “2027 Notes”).”

SWK Holdings Corp underwent a change of control involving Runway Growth Finance Corp. for either 1.7264 shares of RWAY Common Stock or $20.59 in cash, plus $0.74 in cash per share (closed 2026-04-06).

“Time”), each outstanding share of common stock, par value $0.001 per share, of the Company (“Company Common Stock”) was converted into the right to receive (i) either (A) 1.7264 shares of common stock, par value $0.01 per share, of RWAY (“RWAY Common Stock” and such consideration, the “Per Share Stock Consideration”) or (B) $20.59 in cash (the “Per Share”

SWK Holdings Corp amended credit facility of $7.5 million with First Horizon Bank.

“On February 12, 2026, SWK Holdings Corporation (the “Company”), SWK Funding LLC, First Horizon Bank and the financial institutions party thereto entered into a Seventh Amendment to Credit Agreement (the “Amendment”), which amended the Credit Agreement, dated as of June 28, 2023 (as amended by the Amendment, the “Credit Agreement”), by and among the Company, SWK Funding LLC, the lenders party thereto and First Horizon Bank as a lender and agent, in order to, effective as of February 12, 2026, amend the financial covenants and reduce the aggregate commitments thereunder from $10.0 million to $7.5 million.”

SWK Holdings Corp amended credit facility of $60.0 million to $10.0 million with First Horizon Bank.

“On December 4, 2025, SWK Holdings Corporation (the “Company”), SWK Funding LLC, First Horizon Bank and the financial institutions party thereto entered into a Sixth Amendment to Credit Agreement (the “Amendment”), which amended the Credit Agreement, dated as of June 28, 2023 (as amended by the Amendment, the “Credit Agreement”), by and among the Company, SWK Funding LLC, the lenders party thereto and First Horizon Bank as a lender and agent, in order to, effective as of December 4, 2025, reduce the aggregate commitments thereunder from $60.0 million to $10.0 million.”

Marcus Pennington resigned as Director at SWK Holdings Corp.

“On September 30, 2024, Marcus Pennington resigned from the Board of Directors (the “Board”) of SWK Holdings Corporation (the “Company”), effective October 1, 2024 (the “Effective Date”).”

Adam Rice was appointed as Chief Financial Officer at SWK Holdings Corp.

“On July 8, 2024, SWK Holdings, Inc. (the “Company”) announced that on July 3, 2024, the Board of Directors (the “Board”) of the Company, appointed Adam Rice as Chief Financial Officer of the Company, effective as of July 3, 2024.”

SWK Holdings Corp reported the fourth quarter ended December 31, 2023 results: revenue $9.9 million, net income $2.8 million.

“and royalty products targeting innovative life science companies. Fourth Quarter 2023 Financial Results For the fourth quarter 2023, SWK reported total revenue of $9.9 million, a 0.9% increase compared to $9.8 million for the fourth quarter 2022. The increase in revenue for the three months ended December 31, 2023 consisted of a $0.6 million increase”

SWK Holdings Corp entered into Exclusive Option and Asset Purchase Agreement with AptarGroup, Inc. valued at low-single digit million dollar option fee (effective 2024-03-13).

“On March 13, 2024, Enteris Biopharma, Inc. (“Enteris”), a wholly owned subsidiary of SWK Holdings Corporation (“SWK”), and SWK entered into an exclusive option and asset purchase agreement (the “Exclusive Option and Asset Purchase Agreement”) with AptarGroup, Inc. (“Aptar”), pursuant to which Enteris granted to Aptar an exclusive option (the “Option”) to acquire certain of Enteris’s assets related to its business of providing good manufacturing practice (GMP) manufacturing and clinical supply services through Phase 1 and 2 to third parties (collectively, the “Assets”), subject to certain exclusions.”